The Capital Infusion League Table

This probably looks really good on a Bloomberg screen, but the formatting is all screwy online. (Weirdly, the credit-loss league table looks fine.) So as a public service I'll republish today's league table here in a slightly easier-to-read format. Suffice to say, this is one league table you really don't want to top.

Firm	Total Infusion ($bn)	Breakdown ($bn)	Investor
Citigroup	30.4	6.9	Government of Singapore Investment Corp.
		5.6	Kuwait Investment Authority, Alwaleed bin Talal, Capital Research, Capital World, Sandy Weill, public investors
		7.5	Abu Dhabi Investment Authority
		10.4	Public investors
UBS	27.7	10.9	Government of Singapore Investment Corp.
		2	Unidentified Middle Eastern Investor
		14.8	Public investors
IKB Deutsche	13.2		German government, Banking associations
Bank of America	13		Public investors
Merrill Lynch	12.2	6.6	Korea Investment Corp., Kuwait Investment Authority, Mizuho Financial Group
		4.4	Temasek Holdings
		1.2	Davis Selected Advisors
Societe Generale	8.7		Public investors
WestLB	7.8		State of North Rhine Westphalia, savings banks associations, regional governments
Morgan Stanley	5		China Investment Corp.
Barclays	5	3	China Development Bank
		2	Temasek Holdings
Lehman Brothers	4		Public investors
Wachovia	3.5		U.S. investors (unidentified)
Canadian Imperial	2.9	1.5	Li Ka-Shing, Manulife Imperial Financial, Caisse de Depot et Placement du Quebec, OMERS
		1.4	Public investors
Gulf Int'l	1		Governments of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, UAE
TOTAL	135.8

(Via CR)

Add Your Comment

Report Abuse

Archive

Categories

Links